Acquisition by Dandrea Carrie of 19740 shares of Acasti Pharma at 2.96 subject to Rule 16b-3
| ACSTDelisted Stock | USD 3.37 0.01 0.30% |
Slightly above 54% of Acasti Pharma's investor base is interested to short. The analysis of current outlook of investing in Acasti Pharma suggests that many traders are impartial regarding Acasti Pharma's prospects. Acasti Pharma's investing sentiment can be driven by a variety of factors including economic data, Acasti Pharma's earnings reports, geopolitical events, and overall market trends.
Acasti |
Filed transaction by Acasti Pharma Officer Vp Program Management. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Acasti Pharma Fundamental Analysis
We analyze Acasti Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acasti Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acasti Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Acasti Pharma is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Acasti Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acasti Pharma stock to make a market-neutral strategy. Peer analysis of Acasti Pharma could also be used in its relative valuation, which is a method of valuing Acasti Pharma by comparing valuation metrics with similar companies.
Peers
Acasti Pharma Related Equities
| PULM | Pulmatrix | 16.69 | ||||
| OCGN | Ocugen | 6.59 | ||||
| ADTX | Aditxt | 6.06 | ||||
| IBIO | Ibio | 3.54 | ||||
| MBRX | Moleculin Biotech | 2.67 | ||||
| GOVX | GeoVax Labs | 0.37 | ||||
| JAGX | Jaguar Animal | 0.49 | ||||
| AKTX | Akari Therapeutics | 1.75 | ||||
| ABVC | ABVC Biopharma | 1.92 | ||||
| BPTH | Bio Path | 3.74 | ||||
| TNXP | Tonix Pharmaceuticals | 5.00 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Acasti Stock
If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |